What does science say about Metformin and Type 2 diabetes?
- We don’t say yes or no. We show what has been studied.
- Working in a lab or in animals does not mean it works in people.
- Don’t stop or change your treatment without talking to your doctor.
What has been studied
- Lab studies (cells)Tests on cells in a dish.Source: PubMed · as of 9 Nov 2026 · Open the search at PubMed212studies
- Animal studiesTests in mice, rats or other animals.Source: PubMed · as of 9 Nov 2026 · Open the search at PubMed949studies
- Studies in peoplePublished studies with human participants.Source: PubMed · as of 9 Nov 2026 · Open the search at PubMed4325studies
- Registered trials in peopleTrials entered in a public registry, whatever their result.ClinicalTrials.gov: 96 · as of 9 Nov 2026 · Open the search at ClinicalTrials.govEU CTIS: 9 · as of 9 Nov 2026 · Open the search at EU CTISBy phase:Phase 4 (33)No phase (31)Phase 3 (27)Phase 1 (7)Phase 2 (3)Phase 2/3 (2)Phase 1/2 (1)Early Phase 1 (1)By status:Completed (41)Recruiting (25)Running, not recruiting (16)Not yet recruiting (13)Withdrawn before start (5)By invitation only (2)Stopped early (2)Paused (1)Countries (50):China (21)United States (16)Poland (9)Spain (7)Hungary (7)South Korea (7)Pakistan (7)Mexico (6)Bulgaria (5)Germany (5)Egypt (5)Italy (5)Australia (4)Brazil (4)Canada (3)Czechia (3)France (3)Croatia (3)India (3)Iraq (3)Portugal (3)Denmark (2)Greece (2)Latvia (2)Malaysia (2)Nigeria (2)Romania (2)Russia (2)Sweden (2)United Arab Emirates (1)With a linked publication (results): 12 of 105The registries do not tell us here whether results were posted; a linked publication is shown instead.105trials
- Approved treatmentApproved by a medicines regulator for this disease.No
Examples of what we found
The trials
Phase 3
"AMBITION 2: A research study investigating how well zenagamtide lowers blood sugar and body weight compared to placebo in people with type 2 diabetes and chronic kidney disease treated with once daily basal insulin alone or in combination with metformin, SGLT2i, or both."
Not yet recruiting · Czechia, Germany, Poland
EU CTIS · 2026-525471-13-00Phase 3
AMBITION 4: A research study investigating how well zenagamtide at lower dose levels lowers blood sugar and body weight compared to semaglutide at lower dose levels in people with type 2 diabetes treated with metformin, SGLT2i, or both
Recruiting · Bulgaria, Spain, Croatia, Hungary, Poland, Portugal
EU CTIS · 2026-525474-20-00Phase 3
AMBITION 3: A research study investigating how well zenagamtide at higher dose levels lowers blood sugar and body weight compared to semaglutide in people with type 2 diabetes treated with metformin, SGLT2i, or both
Recruiting · Bulgaria, Czechia, Germany, Denmark, Spain, Greece, Croatia, Hungary, Italy, Poland, Portugal, Romania, Slovakia
EU CTIS · 2026-525472-26-00No phase
Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD
Not yet recruiting · China
ClinicalTrials.gov · NCT07778719No phase
Efficacy and Safety of Hebenrun in Patients With Type 2 Diabetes
Not yet recruiting · China
ClinicalTrials.gov · NCT07768280Phase 3
Study of a DPP 4 inhibitor and an SGLT2 inhibitor used together compared with each treatment alone in adults with type 2 diabetes treated with metformin.
Not yet recruiting · Germany, Spain, Italy, Poland, Portugal
EU CTIS · 2025-524606-15-00Phase 2/3
Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers
Running, not recruiting · United States
ClinicalTrials.gov · NCT07033585Phase 4
Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes
By invitation only · Pakistan
ClinicalTrials.gov · NCT07452913Phase 4
Glycemic Variability of Combination Therapies in T2DM
Recruiting · South Korea
ClinicalTrials.gov · NCT07442006No phase
Diabetes Management for Primary Healthcare Centers.
Running, not recruiting · Nigeria
ClinicalTrials.gov · NCT06907472Phase 4
The Effect of Semaglutide on Bone Health
Not yet recruiting · China
ClinicalTrials.gov · NCT07165158Phase 4
Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM
Running, not recruiting · Italy
ClinicalTrials.gov · NCT06860841Phase 4
Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM
Not yet recruiting · China
ClinicalTrials.gov · NCT06762223No phase
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs
Running, not recruiting · Kazakhstan
ClinicalTrials.gov · NCT07303556No phase
Lactic Acidosis and Prior Metformin Treatment
Recruiting · France
ClinicalTrials.gov · NCT07300293Phase 4
Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
Not yet recruiting · United States
ClinicalTrials.gov · NCT06682351Early Phase 1
Precision Dosing of Metformin in Youth With T2D
Recruiting · United States
ClinicalTrials.gov · NCT06120881Phase 3
Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation
Running, not recruiting · Pakistan
ClinicalTrials.gov · NCT07279909Phase 4
Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
Running, not recruiting · United States
ClinicalTrials.gov · NCT05949008No phase
Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes
Running, not recruiting · China
ClinicalTrials.gov · NCT07003191Phase 3
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Recruiting · Australia, Sri Lanka
ClinicalTrials.gov · NCT05345327Phase 4
Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus
Running, not recruiting · Japan
ClinicalTrials.gov · NCT05366868Phase 3
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
Running, not recruiting · United States
ClinicalTrials.gov · NCT05098470No phase
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Running, not recruiting · United States
ClinicalTrials.gov · NCT05220917Phase 3
Study comparing a metformin treatment to standard care to extend time without diabetes after bariatric surgery
Running, not recruiting · France
EU CTIS · NCT04581447No phase
Metformin Effects According to SLC16A11 Carrier Status
Recruiting · Mexico
ClinicalTrials.gov · NCT07760883No phase
"Hepatic Substrate Flux Rates in Type 2 Diabetes"
Running, not recruiting · Germany
ClinicalTrials.gov · NCT04088851No phase
HbA1c Variability in Type II Diabetes
Running, not recruiting · Qatar
ClinicalTrials.gov · NCT02879409No phase
Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS
Running, not recruiting · United States
ClinicalTrials.gov · NCT02087826No phase
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Recruiting · United States
ClinicalTrials.gov · NCT02969798Phase 1/2
Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients
Withdrawn before start · United States
ClinicalTrials.gov · NCT03686657Phase 4
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Completed · Spain
ClinicalTrials.gov · NCT06851962No phase
Antidiabetic Medications and Risk of Cancer
Completed · Hungary
ClinicalTrials.gov · NCT07628556Phase 4
Effect of Continuing Versus Holding Metformin During Hospitalizations.
Stopped early · United States
ClinicalTrials.gov · NCT06296836Phase 2
Polypill Versus Metformin in New Onset Type 2 Diabetes
Withdrawn before start
ClinicalTrials.gov · NCT05833958Phase 3
A study to evaluate the efficacy and safety of gliclazide MR in patients with type 2 diabetes inadequately controlled with dapagliflozin with or without metformin
Completed · Bulgaria, Hungary, Lithuania, Latvia, Poland
EU CTIS · 2024-511408-18-00Phase 3
Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
Withdrawn before start · Bulgaria, Brazil, Greece, Croatia, Hungary, India, Mexico, Malaysia, Poland, Romania, Serbia, Thailand, United States
ClinicalTrials.gov · NCT06083675Phase 3
A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes
Completed · United States
ClinicalTrials.gov · NCT05280496No phase
The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy Trial
Completed · Australia, Canada
ClinicalTrials.gov · NCT05025852Phase 3
Investigational Study of Delayed Release Metformin
Paused · Bulgaria, Brazil, Canada, Czechia, Spain, Hungary, Poland, United States
ClinicalTrials.gov · NCT04854512No phase
Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly
Completed · Spain
ClinicalTrials.gov · NCT04841668Phase 3
Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)
Completed · United Arab Emirates, Belgium, Canada, Colombia, Costa Rica, Dominican Republic, France, United Kingdom, Guatemala, Hungary, Israel, Italy, Mauritius, Mexico, Malaysia, Philippines, Poland, Russia, Saudi Arabia, Ukraine, United States
ClinicalTrials.gov · NCT04029480Phase 2/3
Effectiveness of Dapagliflozin for Weight Loss
Completed · Mexico
ClinicalTrials.gov · NCT03968224No phase
Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes
Completed · Australia
ClinicalTrials.gov · NCT03558867Phase 1
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Completed · United States
ClinicalTrials.gov · NCT01762046
Thinking of paying for it? Read this first
- Ask for published results. Stories, thank-you letters and "patients report" are not results. Ask where the results were published.
- Know what you pay for. Ask in writing: what exactly is included, who gets the money, and what happens if you stop.
- Ask your own doctor first. Some products interfere with chemotherapy, radiation or other medicines. Your treating doctor can check this.
- Do not stop standard treatment for it. Do not stop or delay your treatment without talking to your care team.
Other treatments people ask about
- Cannabis and cannabinoids (CBD, THC)Step: Large trials
- Curcumin (turmeric)Step: Large trials
- Fasting and fasting-mimicking dietStep: Large trials
- High-dose vitamin CStep: Large trials
- HyperthermiaStep: Large trials
- Ketogenic dietStep: Large trials
- MelatoninStep: Large trials
- MetforminStep: Large trials
- StatinsStep: Large trials
- Vitamin DStep: Large trials
- MebendazoleStep: Reports in people
- Dichloroacetate (DCA)Step: Animal studies only
- IvermectinStep: Lab studies only
Not medical advice. Talk to the care team before changing treatment.